Rivaroxaban, an oral, direct factor Xa inhibitor in extended prophylaxis of thromboembolism after total hip replacement: RECORD1

Pas encore traduit Pas encore traduit
Catégorie Primary study
JournalPathophysiology of Haemostasis and Thrombosis
Year 2008

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • RECORD 1 [REgulation of Coagulation in ORthopedic Surgery to Prevent Deep Venous Thrombosis and Pulmonary Embolism 1] (11 documents)
This article is part of the following matrixes of evidence:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: eb4f047a64f5b56814275a2aefd608ee729c2da8
First added on: Aug 22, 2016